Safety issues related to retroviral-mediated gene transfer in humans.
暂无分享,去创建一个
[1] F. Ledley,et al. Correction of methylmalonyl-CoA mutase deficiency inMuto fibroblasts and constitution of gene expression in primary human hepatocytes by retroviral-mediated gene transfer , 1992, Somatic cell and molecular genetics.
[2] A. van der Eb,et al. Gene therapy for human inherited disorders: techniques and status. , 1992, Critical reviews in oncology/hematology.
[3] K. Cornetta,et al. Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. , 1990, The New England journal of medicine.
[4] K. Cornetta,et al. Amphotropic murine leukemia retrovirus is not an acute pathogen for primates. , 1990, Human gene therapy.
[5] R. Sager. Tumor suppressor genes: the puzzle and the promise. , 1989, Science.
[6] R. Callahan,et al. Mutations in human breast cancer: an overview. , 1989, Journal of the National Cancer Institute.
[7] J. Minna,et al. p53: a frequent target for genetic abnormalities in lung cancer. , 1989, Science.
[8] Miller Ad,et al. Improved Retroviral Vectors for Gene Transfer and Expression , 1989 .
[9] J. Willey,et al. Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[10] T. Friedmann,et al. Progress toward human gene therapy. , 1989, Science.
[11] Y. Nakamura,et al. Allelotype of colorectal carcinomas. , 1989, Science.
[12] D. Ledbetter,et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. , 1989, Science.
[13] A. Berns,et al. Predisposition to lymphomagenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors , 1989, Cell.
[14] K. Cornetta,et al. Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapy. , 1989, Journal of virological methods.
[15] E. Golemis,et al. Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses , 1989, Journal of virology.
[16] S. Rosenberg,et al. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. , 1988, The New England journal of medicine.
[17] B. Sefton,et al. Transcriptional activation of lck by retrovirus promoter insertion between two lymphoid-specific promoters , 1988, Journal of virology.
[18] R. Mulligan,et al. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[19] C. Benz,et al. Molecular lesions involved in the progression of a human breast cancer. , 1988, Oncogene.
[20] M. Malim,et al. Complete nucleotide sequence of a mouse VL30 retro-element , 1988, Molecular and cellular biology.
[21] J. Coffin,et al. Highly preferred targets for retrovirus integration , 1988, Cell.
[22] S. Goff,et al. A safe packaging line for gene transfer: separating viral genes on two different plasmids , 1988, Journal of virology.
[23] B. Hjelle,et al. Transforming genes in chronic myelogenous leukemia. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[24] A. Rabson,et al. Potential progenitor sequences of mink cell focus-forming (MCF) murine leukemia viruses: ecotropic, xenotropic, and MCF-related viral RNAs are detected concurrently in thymus tissues of AKR mice , 1988, Journal of virology.
[25] G. Shen-Ong,et al. BALB/c Mice: Requirement of c-myb Activation but Lack of v-abl Involvement , 2022 .
[26] J. Mietz,et al. Nucleotide sequence of a complete mouse intracisternal A-particle genome: relationship to known aspects of particle assembly and function , 1987, Journal of virology.
[27] T. Taniguchi,et al. Retroviral expression of the human IL‐2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity. , 1987, The EMBO journal.
[28] P. Kantoff,et al. Expression of human adenosine deaminase in nonhuman primates after retrovirus-mediated gene transfer , 1987, The Journal of experimental medicine.
[29] M. Nicolson,et al. Replication-defective chimeric helper proviruses and factors affecting generation of competent virus: expression of Moloney murine leukemia virus structural genes via the metallothionein promoter , 1987, Molecular and cellular biology.
[30] M. Bender,et al. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region , 1987, Journal of virology.
[31] E. Golemis,et al. Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides , 1987, Journal of virology.
[32] R. Jaenisch,et al. Retrovirus integration and chromatin structure: Moloney murine leukemia proviral integration sites map near DNase I-hypersensitive sites , 1987, Journal of virology.
[33] Jos Domen,et al. The primary structure of the putative oncogene pim-1 shows extensive homology with protein kinases , 1986, Cell.
[34] K. Isselbacher,et al. Expression of type C-related endogenous retroviral sequences in human colon tumors and colon cancer cell lines. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[35] A. Miller,et al. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production , 1986, Molecular and cellular biology.
[36] J. Levy,et al. The AIDS-associated retrovirus is not sensitive to lysis or inactivation by human serum. , 1986, Virology.
[37] A. Miller,et al. Factors involved in production of helper virus-free retrovirus vectors , 1986, Somatic cell and molecular genetics.
[38] B. Sefton,et al. Expression of a new tyrosine protein kinase is stimulated by retrovirus promoter insertion , 1986, Nature.
[39] E. Krebs,et al. A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA , 1985, Cell.
[40] M. Martin,et al. Characterization of human endogenous retroviral envelope RNA transcripts , 1985, Journal of virology.
[41] M. Martin,et al. Nucleotide sequence of a full-length human endogenous retroviral segment , 1985, Journal of virology.
[42] E. Linney,et al. Suppression of leukaemia virus pathogenicity by polyoma virus enhancers , 1985, Nature.
[43] I. Verma,et al. Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene , 1985, Molecular and cellular biology.
[44] M. Zijlstra,et al. Involvement of c‐myc in MuLV‐induced T cell lymphomas in mice: frequency and mechanisms of activation. , 1984, The EMBO journal.
[45] T. Hunter,et al. Characterization of the protein apparently responsible for the elevated tyrosine protein kinase activity in LSTRA cells , 1984, Molecular and cellular biology.
[46] W. Anderson,et al. Prospects for human gene therapy. , 1984, The Journal of reproductive medicine.
[47] N. Hopkins,et al. A 3' end fragment encompassing the transcriptional enhancers of nondefective Friend virus confers erythroleukemogenicity on Moloney leukemia virus , 1984, Journal of virology.
[48] R. Mulligan,et al. High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[49] J. Sorge,et al. Amphotropic retrovirus vector system for human cell gene transfer , 1984, Molecular and cellular biology.
[50] C. Kozak,et al. Cellular DNA region involved in induction of thymic lymphomas (Mlvi-2) maps to mouse chromosome 15 , 1984, Molecular and cellular biology.
[51] Wim Quint,et al. Murine leukemia virus-induced T-cell lymphomagenesis: Integration of proviruses in a distinct chromosomal region , 1984, Cell.
[52] S. Cory,et al. Murine T lymphomas in which the cellular myc oncogene has been activated by retroviral insertion , 1984, Cell.
[53] D. Steffen. Proviruses are adjacent to c-myc in some murine leukemia virus-induced lymphomas. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[54] H. Temin,et al. Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors , 1983, Molecular and cellular biology.
[55] Robert A. Weinberg,et al. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes , 1983, Nature.
[56] N. Hopkins,et al. Role for the 3' end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[57] E. Keshet,et al. Conservation patterns of mouse "virus-like" (VL30) DNA sequences. , 1983, Virology.
[58] D. Baltimore,et al. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus , 1983, Cell.
[59] T. Bonner,et al. Cloned endogenous retroviral sequences from human DNA. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[60] L. Schmidt,et al. Organization and expression of endogenous virus-like (VL30) DNA sequences in nontransformed and chemically transformed mouse embryo cells in culture. , 1982, Cancer research.
[61] D. Lowy,et al. Cellular origin and role of mink cell focus-forming viruses in murine thymic lymphomas , 1982, Nature.
[62] M. Cole,et al. Sequence organization of cloned intracisternal a particle genes , 1980, Cell.
[63] K. Lueders,et al. Intracisternal A-particle genes: identification in the genome of Mus musculus and comparison of multiple isolates from a mouse gene library. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[64] J W Hartley,et al. Lymphomagenicity of recombinant mink cell focus-inducing murine leukemia viruses , 1980, The Journal of experimental medicine.
[65] S. Chattopadhyay,et al. Biochemical characterization of the amphotropic group of murine leukemia viruses , 1978, Journal of virology.
[66] E. Scolnick,et al. Characterizatiion of rat genetic sequences of Kirsten sarcoma virus: distinct class of endogenous rat type C viral sequences , 1976, Journal of virology.
[67] R. Bassin,et al. Isolation of murine sarcoma virus‐transormed mouse cells which are negative for leukemia virus from agar suspension cultures , 1970 .
[68] H. Duc-Nguyen. Enhancing effect of diethylaminoethyl-dextran on the focus-forming titer of a murine sarcoma virus (Harvey strain) , 1968, Journal of virology.
[69] K. Cornetta,et al. No retroviremia or pathology in long-term follow-up of monkeys exposed to a murine amphotropic retrovirus. , 1991, Human gene therapy.
[70] K. Cornetta,et al. Applications of the polymerase chain reaction in retroviral-mediated gene transfer and the analysis of gene-marked human TIL cells. , 1990, Human gene therapy.
[71] A. Miller. Retrovirus packaging cells. , 1990, Human gene therapy.
[72] M. Hatzoglou,et al. Efficient packaging of a specific VL30 retroelement by psi 2 cells which produce MoMLV recombinant retroviruses. , 1990, Human gene therapy.
[73] S. Rosenberg,et al. Selection of gene-marked tumor infiltrating lymphocytes from post-treatment biopsies: a case study. , 1990, Human gene therapy.
[74] K. Nason-Burchenal,et al. Retrovirus-induced tumors whose development is facilitated by a chronic immune response: a comparison of two tumors committed to the monocytic lineage. , 1989, Current topics in microbiology and immunology.
[75] W. Haseltine. Development of antiviral drugs for the treatment of AIDS: strategies and prospects. , 1989, Journal of acquired immune deficiency syndromes.
[76] L. Evans,et al. Friend and Moloney murine leukemia viruses specifically recombine with different endogenous retroviral sequences to generate mink cell focus-forming viruses. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[77] H. Ozer,et al. Some structural and antigenic properties of intracisternal A particles occurring in mouse tumors (complement fixation-immunodiffusion-neuroblastoma-plasma-cell tumor). , 1972, Proceedings of the National Academy of Sciences of the United States of America.